Results 231 to 240 of about 730,939 (432)

Revascularization of coronary chronic total occlusion in patients with end stage renal disease. [PDF]

open access: yesSci Rep
Tsai CT   +7 more
europepmc   +1 more source

A Feedback Loop Between Fatty Acid Metabolism and Epigenetics in Clear Cell Renal Carcinoma

open access: yesAdvanced Science, EarlyView.
The current study has profiled the landscape of active enhancers in ccRCC and identified FABP5 as an oncogene. FABP5 is essential for the lipid droplet formation driven by HIFs and critical for H3K27ac and enhancer activity. The study has discovered the function of a feedback loop between epigenetics and lipid metabolism regulated by FABP5 in ccRCC ...
Zhou Ye   +21 more
wiley   +1 more source

The Immune Microenvironment: New Therapeutic Implications in Organ Fibrosis

open access: yesAdvanced Science, EarlyView.
This review summarizes recent advances in understanding the immune microenvironment's role in fibrosis, focusing on phenotypic/functional alterations of immune cells and their dynamic interactions with other cellular constituents within tissues. The authors further explore therapeutic opportunities and challenges in targeting immune microenvironment ...
Xiangqi Chen   +6 more
wiley   +1 more source

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis

open access: yesJournal of clinical pharmacology, 2016
Xiaoli Wang   +9 more
semanticscholar   +1 more source

End-Stage Renal Disease in US Minority Groups

open access: hybrid, 1992
Harold I. Feldman   +3 more
openalex   +1 more source

Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease [PDF]

open access: bronze, 1999
Sylvain J. Marchais   +3 more
openalex   +1 more source

History of Childhood Kidney Disease and Risk of Adult End‐Stage Renal Disease

open access: yesNew England Journal of Medicine, 2018
R. Calderon-Margalit   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy